NORPLANT SYSTEM IN PLASTIC CONTAINER Drug Patent Profile

✉ Email this page to a colleague

When do Norplant System In Plastic Container patents expire, and what generic alternatives are available?

Norplant System In Plastic Container is a drug marketed by Wyeth Pharms Inc and is included in one NDA.

The generic ingredient in NORPLANT SYSTEM IN PLASTIC CONTAINER is levonorgestrel. There are twenty drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Norplant System In Plastic Container

A generic version of NORPLANT SYSTEM IN PLASTIC CONTAINER was approved as levonorgestrel by NOVEL LABS INC on February 22^nd, 2013.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for NORPLANT SYSTEM IN PLASTIC CONTAINER?
What are the global sales for NORPLANT SYSTEM IN PLASTIC CONTAINER?
What is Average Wholesale Price for NORPLANT SYSTEM IN PLASTIC CONTAINER?

Summary for NORPLANT SYSTEM IN PLASTIC CONTAINER

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	104
Clinical Trials:	7
Patent Applications:	4,686
DailyMed Link:	NORPLANT SYSTEM IN PLASTIC CONTAINER at DailyMed

Drug patent expirations by year for NORPLANT SYSTEM IN PLASTIC CONTAINER

Recent Clinical Trials for NORPLANT SYSTEM IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Women and Infants Hospital of Rhode Island	N/A
Oregon Health and Science University	Phase 4
Society of Family Planning	Phase 4

See all NORPLANT SYSTEM IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for NORPLANT SYSTEM IN PLASTIC CONTAINER

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wyeth Pharms Inc	NORPLANT SYSTEM IN PLASTIC CONTAINER	levonorgestrel	IMPLANT;IMPLANTATION	020088-001	Dec 10, 1990		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for NORPLANT SYSTEM IN PLASTIC CONTAINER

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Wyeth Pharms Inc	NORPLANT SYSTEM IN PLASTIC CONTAINER	levonorgestrel	IMPLANT;IMPLANTATION	020088-001	Dec 10, 1990	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for NORPLANT SYSTEM IN PLASTIC CONTAINER

See the table below for patents covering NORPLANT SYSTEM IN PLASTIC CONTAINER around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
France	1393968	Substances stéroïdes dérivant de la 19-nortestostérone et leurs procédés de préparation	⤷ Sign Up
Sweden	322213		⤷ Sign Up
Philippines	11432	SYNTHESIS OF 13-POLYCARBONALKYLGONA-2,5(10)-DIENE-17-OLS	⤷ Sign Up
Germany	1443123		⤷ Sign Up
Sweden	354064		⤷ Sign Up
India	139096	PROCESS FOR PREPARING 13-ETHYLYON-4-ENES	⤷ Sign Up
Sweden	308309		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for NORPLANT SYSTEM IN PLASTIC CONTAINER

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1453521	300814	Netherlands	⤷ Sign Up	PRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211
1453521	CA 2016 00016	Denmark	⤷ Sign Up	PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211
1453521	15C0050	France	⤷ Sign Up	PRODUCT NAME: ETHINYLESTRADIOL ET MELANGE DE LEVONORGESTREL ET ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: NL 42237 20150320; FIRST REGISTRATION: SK - 17/0017/15-S 20150129
1453521	C 2015 029	Romania	⤷ Sign Up	PRODUCT NAME: LEVONORGESTREL SI ETINILESTRADIOL; NATIONAL AUTHORISATION NUMBER: RO 7793/2015/001; DATE OF NATIONAL AUTHORISATION: 20150612; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): SK. 17/0017/15-S; DATE OF FIRST AUTHORISATION IN EEA: 20150129
1453521	C201630040	Spain	⤷ Sign Up	PRODUCT NAME: ETINILESTRADIOL Y MEZCLA DE LEVONORGESTREL Y ETINILESTRADIOL; NATIONAL AUTHORISATION NUMBER: 80340; DATE OF AUTHORISATION: 20160122; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): 17/0017/15-S; DATE OF FIRST AUTHORISATION IN EEA: 20150211
1453521	132016000025143	Italy	⤷ Sign Up	PRODUCT NAME: LEVONORGESTREL ED ETINILESTRADIOLO(SEASONIQUE); AUTHORISATION NUMBER(S) AND DATE(S): 17/0017/15-S, 20150211;042139016, 20150414
1453521	93156	Luxembourg	⤷ Sign Up	PRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

AI Research Assistant

Questions you can ask:

Summary for NORPLANT SYSTEM IN PLASTIC CONTAINER

Recent Clinical Trials for NORPLANT SYSTEM IN PLASTIC CONTAINER

Make Better Decisions: Try a trial or see plans & pricing